Project Livin’ Label is a new educational initiative that aims to foster broad understanding of the associated oncology product label and increase awareness of recent oncology drug FDA approvals in the cancer community.

Using oncology product labeling as a roadmap, the FDA’s Oncology Center of Excellence (OCE) will guide discussions between an FDA reviewer, a clinical trial investigator, a patient, and the company on the backstory of the oncology product development and FDA review process.

Join us as the OCE highlights select cancer therapeutics’ clinical development programs and releases knowledge about the oncology products’ clinical journey from development to approval.